Equities
  • Price (EUR)400.10
  • Today's Change6.90 / 1.75%
  • Shares traded100.00
  • 1 Year change+1.06%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year IDEXX Laboratories Inc grew revenues 8.72% from 3.37bn to 3.66bn while net income improved 24.44% from 679.09m to 845.04m.
Gross margin60.72%
Net profit margin22.53%
Operating margin28.92%
Return on assets26.91%
Return on equity59.42%
Return on investment38.86%
More ▼

Cash flow in USDView more

In 2023, IDEXX Laboratories Inc increased its cash reserves by 303.33%, or 341.39m. The company earned 906.51m from its operations for a Cash Flow Margin of 24.76%. In addition the company used 125.25m on investing activities and also paid 442.00m in financing cash flows.
Cash flow per share11.87
Price/Cash flow per share35.76
Book value per share19.72
Tangible book value per share13.40
More ▼

Balance sheet in USDView more

IDEXX Laboratories Inc has a Debt to Total Capital ratio of 35.07%, a lower figure than the previous year's 47.70%.
Current ratio1.42
Quick ratio1.03
Total debt/total equity0.5401
Total debt/total capital0.3507
More ▼

Growth rates in USD

SmartText is unavailable
EPS growth(5 years)18.62
EPS (TTM) vs
TTM 1 year ago
5.75
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.